Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05536011 · ClinicalTrials.gov registry record

WAKIX® (Pitolisant) Pregnancy Registry

A clinical trial of Pregnancy Related and Narcolepsy, sponsored by Harmony Biosciences Management.

Recruiting
Registry status
1,329
Enrollment target
1
Study location

NCT05536011 is a study of Pregnancy Related and Narcolepsy that is actively recruiting participants, run by Harmony Biosciences Management. The registered enrollment target is 1,329 participants, below the 1,950-participant average among 99 other Pregnancy Related trials with a reported enrollment target (32% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05536011, a study of Pregnancy Related and Narcolepsy, is actively recruiting participants, sponsored by Harmony Biosciences Management.

RECRUITING
Registry status
1,329 participants
Enrollment target
1
Study location

Study Summary

The WAKIX (pitolisant) Pregnancy Registry is a US-based, prospective, observational cohort study designed to evaluate the association between pitolisant exposure during pregnancy and subsequent maternal, fetal, and infant outcomes.

Interventions

  • DRUG Pitolisant
  • DRUG Comparator Products

Study Locations (1)

North Carolina

  • Evidera (PPD) - Morrisville

Trial Details

FieldValue
Enrollment Target 1,329 participants
Start Date 2021-08-24
Est. Completion 2030-06-30

Sponsor

Harmony Biosciences Management

10 total trials

What the Registry Record Tells You About NCT05536011

The ClinicalTrials.gov registry entry for NCT05536011 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,329 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,950-participant average among 99 other Pregnancy Related trials with a reported enrollment target (32% lower). The listed sponsor is Harmony Biosciences Management, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 2 interventions - of which Pitolisant is the first listed.

NCT05536011 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05536011 about?

NCT05536011 is a clinical study titled "WAKIX® (Pitolisant) Pregnancy Registry". The WAKIX (pitolisant) Pregnancy Registry is a US-based, prospective, observational cohort study designed to evaluate the association between pitolisant exposure during pregnancy and subsequent maternal, fetal, and infant outcomes.

What is the current status of trial NCT05536011?

This trial is currently recruiting. The enrollment target is 1,329 participants. The study started on 2021-08-24. Estimated completion is 2030-06-30.

What conditions does trial NCT05536011 study?

This clinical trial studies the following conditions: Pregnancy Related, Narcolepsy.

What interventions are being tested in trial NCT05536011?

The interventions under investigation include: Pitolisant (DRUG), Comparator Products (DRUG).

Who is sponsoring clinical trial NCT05536011?

This trial is sponsored by Harmony Biosciences Management, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05536011 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy Related

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.